The SUSTAIN for Bispecific Antibody (BsAb) Therapy Program is an online continuing education curriculum that equips community oncology teams with the knowledge and tools needed to safely implement BsAb therapy for patients with multiple myeloma. Based on the University of Kentucky's experience, this practical, multidisciplinary program helps oncology practices expand access to innovative myeloma care, particularly in rural and underserved communities.